Valganciclovir

A prodrug of ganciclovir. It is highly effective against CMV, which can be life-threatening in immunocompromised children or infants with congenital CMV.

Dosage by Body Weight

Pediatric dosing is complex, often calculated using the Mosteller Body Surface Area formula and creatinine clearance. For neonates with congenital CMV: 16 mg/kg twice daily.

Body Weight
3-6 kg (Neonate)
Dose
48 mg to 96 mg
Frequency
Twice daily
Tracking Notes
Must be taken with food. Handle with gloves (cytotoxic).

Weight-based dosage tracking table for Valganciclovir, including body weight, dose, frequency, and tracking notes.
Body Weight	Dose	Frequency	Tracking Notes
3-6 kg (Neonate)	48 mg to 96 mg	Twice daily	Must be taken with food. Handle with gloves (cytotoxic).

Formulation

Oral SolutionTablet

Purpose

Treatment of Cytomegalovirus (CMV) retinitis and prevention of CMV disease in transplant recipients.

Generic Name

Valganciclovir Hydrochloride

Branded Drug Names

Valganciclovir is listed as a generic drug name. Common branded medicines that may contain the same active ingredient include:

Valcyte

Scheduled Drug

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

Alternatives

GanciclovirFoscarnet